Department of Medicine
Protecting global health
Our faculty researchers develop new, and improve existing, vaccines to better protect the health of all individuals across the globe. Our group consists of a dynamic team of physicians, nurses, study coordinators, laboratory personnel, and volunteers. Our research studies are designed for the development of vaccines and, importantly, for maximum volunteer safety. All studies are reviewed by the ethics review board (Institutional Review Board, IRB) of the University of Vermont.
Our team runs a fully functioning unit for performing phase I and II vaccine trials and enteric challenge models at the Vaccine Testing Center (VTC). In general, the VTC focuses on the development of vaccines of importance to global health, including typhoid fever, Campylobacter infections and dengue viral diseases. In 2009, the VTC began a 5- year project with Johns Hopkins University to study new Dengue and West Nile Vaccines. Other collaborators have included biotech companies, the National Institutes of Health and the Department of Defense.
Infectious Disease Division
Many of our faculty researchers are from our academic Infectious Disease unit, a division of the Department of Medicine.
Dr. Beth Kirkpatrick received her M.D. in 1992 from Albany Medical College and completed an internship, residency and chief residency in Internal Medicine at the University of Rochester. She was a Fellow in Infectious Diseases at Johns Hopkins from 1996-1999, and joined the faculty of UVM in 1999. Dr. Kirkpatrick has been board-certified in Internal Medicine and Infectious Diseases, and holds a certificate of knowledge in tropical medicine and travelers’ health.
Vaccine Testing Center in the News
Last modified February 29 2012 02:07 PM